ANI Pharmaceuticals, Inc. (BSFA.F)

62,00 0,00 (0,00%) Ab 09:59AM CEST. Markt geöffnet.

ANI Pharmaceuticals, Inc.

210 Main Street West
Baudette, MN 56623
United States
218 634 3500
https://www.anipharmaceuticals.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 642

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Nikhil Lalwani	President, CEO & Director	2,16M	346,94k	1978
Mr. Stephen P. Carey	Senior VP of Finance & CFO	1,03M	N/A	1971
Mr. Chad Gassert	Senior Vice President of Corporate Development & Strategy	789,88k	N/A	1976
Mr. Christopher K. Mutz	Senior Vp & Head of Rare Disease	806,8k	N/A	1972
Mr. Ori Gutwerg	Senior Vice President of Generics	832,12k	405,53k	1975
Mr. Muthusamy Shanmugam MS R.Ph.	Head of R&D, COO of Novitium Operations & Director	N/A	N/A	1968
Mr. James G. Marken	Senior Vice President of Operations & Product Development	625,82k	N/A	1963
Ms. Meredith W. Cook	Senior VP, General Counsel & Corporate Secretary	N/A	N/A	1975
Ms. Krista L. Davis	Senior VP & Chief Human Resources Officer	N/A	N/A	1974
Ms. Elizabeth Powell J.D.	Chief Compliance Officer & Head of Legal of Rare Disease	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Corporate Governance

ANI Pharmaceuticals, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 2. Die grundlegenden Scores sind Audit: 8, Vorstand: 3, Shareholderrechte: 1, Kompensation: 3.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.